Related Experiment Video
Updated: Mar 19, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation
Rafael Peres1, Hideki Furuya1, Ian Pagano2
1University of Hawaii Cancer Center, Clinical & Translational Research Program, Honolulu, HI, USA.
Abstract:
Epigenetic-mediated gene activation/silencing plays a crucial role in human tumorigenesis. Eliciting the underlying mechanism behind certain epigenetic changes is essential for understanding tumor biology. Previous studies in human cancers revealed an unrecognized interplay between Angiogenin (ANG) and matrix metalloproteinase-2 (MMP2) leading to pronounced tumorigenesis. Here we provide multiple lines of evidence further indicating ANG oncogenic potential. ANG expression resulted in the hypomethylated state of the MMP2 gene, which led to increased gene expression of MMP2. More than that, our global DNA methylation microarray analysis showed that gene manipulation of ANG affected a variety of pathways, such as cell migration, angiogenesis and specifically, tumor suppressor genes. Mechanistically, ANG negatively regulated DNA methyltransferase 3b (DNMT3b) enzymatic activity by down-regulating its expression and inhibiting its recruitment to the MMP2 promoter. Consistent with this, ANG-MMP2 overexpression and DNMT3b underexpression correlated with reduction in disease free survival of human bladder cancer patients. Together, the results continue to establish ANG as an oncoprotein and further reveal that ANG contributes to oncogenesis by the activation of MMP2 through modulation of DNMT3b functions.
Insights
Angiogenin (ANG) activates matrix metalloproteinase-2 (MMP2) by altering DNA methylation, promoting human tumorigenesis. This mechanism involves downregulating DNA methyltransferase 3b (DNMT3b), impacting cancer patient survival.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- Epigenetic gene regulation is critical in human cancer development.
- Previous research identified an interplay between Angiogenin (ANG) and matrix metalloproteinase-2 (MMP2) in tumorigenesis.
Purpose of the Study:
- To elucidate the oncogenic potential of ANG and its mechanism in human cancer.
- To investigate the role of ANG in regulating MMP2 expression and its epigenetic modifications.
Main Methods:
- DNA methylation microarray analysis.
- Gene expression analysis of ANG, MMP2, and DNMT3b.
- Assessment of DNMT3b activity and promoter recruitment.
Main Results:
- ANG expression led to hypomethylation and increased expression of the MMP2 gene.
- ANG manipulation affected cell migration, angiogenesis, and tumor suppressor gene pathways.
- ANG negatively regulated DNMT3b expression and activity, inhibiting its binding to the MMP2 promoter.
- ANG overexpression and MMP2 overexpression, along with DNMT3b underexpression, correlated with reduced disease-free survival in bladder cancer patients.
Conclusions:
- ANG functions as an oncoprotein by activating MMP2 through epigenetic mechanisms.
- ANG contributes to oncogenesis by modulating DNMT3b activity, leading to MMP2 activation.
- The ANG-MMP2 pathway and DNMT3b levels serve as potential prognostic markers for human bladder cancer.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Mechanism of Angiogenesis
The Tumor Microenvironment
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

